SOLICITATION NOTICE
A -- DAIDS Enterprise Systems (DAIDS-ES) Development
- Notice Date
- 3/28/2003
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700 B Rockledge Room 2230 MSC7612, Bethesda, MD, 20892-7605
- ZIP Code
- 20892-7605
- Solicitation Number
- RFP-NIH-NIAID-DAIDS-03-60
- Archive Date
- 5/29/2003
- Point of Contact
- Liem Nguyen, Contract Specialist, Phone 301-496-0612, Fax 301-480-5253, - Barbara Shadrick, Senior Contracting Officer, Phone 301-496-7288, Fax 301-480-5253,
- E-Mail Address
-
LNguyen@niaid.nih.gov, bs92y@nih.gov
- Description
- The National Institutes of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS), intends to negotiate with Capital Technology Information Services, Inc. (CTIS) for a multiple-year contract to continue the Phase II design, development, deployment and operations of the Division of AIDS (DAIDS) Enterprise System (DAIDS-ES), and DAIDS Adverse Experience Reporting System (DAERS). THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. CTIS has worked for over a decade with NIH clinical research management systems, including the National Cancer Institute (NCI) Clinical Trials Enterprise System. CTIS designed, developed and deployed NCI?s Adverse Event Expediting Reporting System (AdEERS), in use throughout the NCI?s cooperative clinical trials groups. To meet DAIDS? requirement for the DAIDS-ES, CTIS is working with DAIDS to tailor and pilot DAERS, their adapted version of AdEERS. CTIS?s institutional knowledge of the AdEERS system is crucial and essential to the successful adaptation, piloting and final deployment of the DAERS. This project was initiated by DAIDS for an analysis and re-engineering of business processes and the development of an enterprise wide research information management system (Phase I, Pilot Study) through a subcontract with Capital Technology Information Services (CTIS) and Digital Infuzion (DIFZ) under a contract with B.L. Seamon (NO1-AI-75323). Support for Phase I of this project was continued by contracting with these same firms through the National Cancer Institute?s Technical and Professional Services (NCI-TPS) mechanism -- (Contract # NO2-CO-24005 entitled ?Analysis and Reengineering of DAIDS Business Process and the Architectural Development of a DAIDS Enterprise System?). The NCI-TPS expired in December 2002, resulting in DAIDS? Task Order with CTIS expiring on March 31, 2003. In order to continue this project, another task order for Phase II, for the design, development, deployment and operations of the DAIDS-ES, was competitively solicited using the NITAAC/CIO-SP2I mechanism with the award being made for a period of five months from April 1, 2003 through August 31, 2003 to Science Applications International Corporation (SAIC), subcontracting with Capital Technology Information Services. All work is being performed under the CTIS subcontract with no major contributions by SAIC as prime. Upon completion of this NITAAC Task Order, DAIDS will be awarding the contract for the completion of the DAIDS-ES to CTIS, thereby establishing a direct contractual relationship with the firm performing this project and provide cost savings to the Government. CTIS has responded to DAIDS? need for automated, accurate and expedited safety reporting that is mission critical to insure DAIDS adherence with applicable regulatory requirements and guidelines through the development of this safety reporting system for DAIDS? large portfolio of clinical trials, as discussed above by completing Phase I and now initiating the start-up of Phase II. Due to the progress that CTIS has made in this endeavor, the CTIS team possesses unique capabilities and demonstrated their understanding of DAIDS and its Networks. It is critical that this existing relationships, architectural knowledge and institutional knowledge base be maintained to ensure the success of the DAIDS-ES/DAERS. The CTIS team has completed significant work on the DAERS. Beta testing for the DAERS is planned to begin early April, 2003. The Safety Reporting System must be fully operational in 2004. It is critical that this work remain uninterrupted and on schedule. Any delay could compromise the ability of DAIDS to conduct their research trials and meet commensurate mandatory safety reporting requirements. The CTIS team has a critical understanding of the DAIDS business and clinical research environment and has provided technical leadership in its work performed on Phases I and II of the DAIDS-ES development. It is also the intent of the DAIDS to use CTIS?s proprietary Commercial-Off-the-Shelf Software (COTS) TrialBridge?, which will be a critical component framework and tool for the successful design, development, deployment and operations of the DAIDS-ES system. CTIS shall furnish all necessary services, qualified personnel, material, equipment and processes for the DAIDS-ES. With an incredibly large and complex clinical trials portfolio of over 300 sites and 30 countries, the DAIDS must be able to continue the development of the DAIDS-ES with CTIS and DIFZ in order to organize and proactively manage and maintain the critical information systems infrastructure for the DAIDS clinical trials and business management. The statutory authority justifying this other than full and open competition is 41 U.S.C. 253(c)(1), and FAR 6.302-1(b)(1), unique capabilities, e.g., supplies or services. Interested parties may identify their interest and capability to respond to the requirement if they are able to perform the requirement with the required level of continuity. Responses must be received on/before the closing date noted above. See Numbered Note 22. No collect calls will be accepted.
- Record
- SN00290263-W 20030330/030328213426 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |